RAPTIVA Pages on BioPortfolio:

Biotechnology News RAPTIVA Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/RAPTIVA-news.htm...

BioPortfolio - Raptiva
Raptiva - BioPortfolio - Indepth. ... Companies working in the area of Raptiva from Bioportfolio's Biocorporate database : BioPortfolio Logo. Company Name ...
http://www.bioportfolio.com/indepth/Raptiva.html...

BioPortfolio.com - BioWeb OMNITROPE SOMATROPIN RECOMBINANT isrupt ...
Home Contact Us Site Index Search [ Products -- Nutropin ] Products Home ONCOLOGY Avastin Herceptin Rituxan Tarceva IMMUNOLOGY Raptiva Xolair VASCULAR
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?DB=se...

BioPortfolio - - European Medicines Agency Recommends Suspension ...
Recommends Suspension of Marketing Authorization for Raptiva(R). Tuesday 9 December 2008 ... http://www.prnewswire.co.uk/cgi/news/company?id=236465. ...
http://www.bioportfolio.com/news/European_Medicines_Agency_R...

Wong's BioTech Stock Report - focus on the pipeline Fabrazyme ...
Genentech will co-promote Xolair and Raptiva with Xoma (NASDAQ: XOMA) and Novartis AG ... While the odds of marketing approval looks promising for Raptiva
, ...
http://www.bioportfolio.com/news/biotechsage_6.htm...

BioPortfolio Limited Stakeholder Opinions: Physician perception of ...
Raptiva hit by multifocal leukoencephalopathy side-effect 98 .... Figure 41: Raptiva's weighted score compared to all physicians average scores and ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_16.html...

Psoriasis: Biologics hope to reach 8mill undiagnosed sufferers
The current leading biologics are Biogen Idec and Genentech's Amevive; Serono, Genentech and XOMA's Raptiva; Wyeth and Amgen's Enbrel and Johnson and ...
http://www.bioportfolio.com/news/datamonitor_115.htm...

BioPortfolio Limited Stakeholder Opinions: Physician perception of ...
Raptiva hit by multifocal leukoencephalopathy side-effect 98 ... Table 25: Raptiva's scores by attribute and country, from dermatologists 101 ...
http://www.bioportfolio.com/cgi-bin/acatalog/2075.html...

BioPortfolio Limited Stakeholder Insight: Psoriasis - Biologics ...
Remicade and Raptiva are the clear favorites at third line 99 ... Raptiva's safety profile continues to signal doom for the brand 114 ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_19.html...

BioPortfolio News: BioPortfolio BioTrends Research Group, Inc ...
EXTON, Pa., April 10 /PRNewswire/ -- On April 8th, 2009, Genentech and Roche announced the voluntary withdrawal of Raptiva (efalizumab, marketed by ...
http://www.bioportfolio.com/news/company/BioTrends_Research_...

Results from other life science and pharmaceutical sites:

Genentech: Medicines: Raptiva
Raptiva is a humanized therapeutic antibody designed to selectively and reversibly block the activation, reactivation and trafficking of T-cells that
lead ...
http://www.gene.com/gene/products/information/immunological/...

Efalizumab - Wikipedia, the free encyclopedia
Efalizumab (trade name Raptiva, Genentech, Merck Serono) is a medication designed to treat psoriasis. As its name implies, it is a recombinant humanized
...
http://en.wikipedia.org/wiki/Efalizumab...

Genentech: Newsroom: Press Releases: News Release April 8, 2009
8 Apr 2009 ... April 8, 2009 -- Genentech, Inc. announced today a phased voluntary withdrawal of the psoriasis drug Raptiva® (efalizumab) from the U.S. ...
http://www.gene.com/gene/news/press-releases/display.do?meth...

FDA Statement on the Voluntary Withdrawal of Raptiva From the U.S. ...
8 Apr 2009 ... Today, Genentech, the manufacturer of the psoriasis drug Raptiva (efalizumab), announced that it has begun a voluntary, phased withdrawal of ...
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/uc...

RAPTIVA USPI
been observed in patients treated with RAPTIVA (see WARNINGS and .... patients who resumed RAPTIVA treatment upon relapse of psoriasis, 31% (17/55) ...
http://www.gene.com/gene/products/information/pdf/raptiva-pr...

Raptiva (efalizumab) Feb 2009
[UPDATE 04/08/2009] Genentech and FDA notified healthcare professionals of the voluntary, phased withdrawal of Raptiva, a medication for treatment of ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyA...

Genentech: Investors: Raptiva - Historical Sales
Skip to Content for Raptiva - Historical Sales Menu for Raptiva - Historical Sales About Us Menu Research Menu Development Menu Medicines Menu Investors ...
http://www.gene.com/gene/ir/financials/historical/raptiva.ht...

VOLUNTARY U.S. MARKET WITHDRAWAL OF RAPTIVA® (efalizumab)
8 Apr 2009 ... voluntary withdrawal of the psoriasis medication RAPTIVA ... clinical benefit from RAPTIVA, the balance between benefit and risk in the ...
http://www.fda.gov/downloads/Safety/MedWatch/SafetyInformati...

MEDICATION GUIDE RAPTIVA® (Rap-TEE-vah) (efalizumab) for injection ...
Before you start using RAPTIVA, tell your doctor if you have an infection. During your RAPTIVA treatment, tell your doctor ...
http://www.gene.com/gene/products/information/pdf/raptiva_me...

Roche - Roche and Genentech announce voluntary withdrawal of ...
8 Apr 2009 ... The company's decision is based on the association of Raptiva with an increased risk ... Raptiva is indicated for the treatment of chronic ...
http://www.roche.com/investors/ir_update/inv-update-2009-04-...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.